CD44 and cancer: More importantly, we also explored the cell stemness of six-FBXOs in PDAC by using the GSE51971 dataset, whose data were classified into triple-positive group and triple-negative group according to whether these expressed the three important cancer stem cell markers, CD44, CD133, and EpCAM.